Spectral AI, Inc.

MDAI Nasdaq CIK: 0001833498

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 2515 MCKINNEY AVE #1000, DALLAS, TX, 75201
Mailing Address 2515 MCKINNEY AVE #1000, DALLAS, TX, 75201
Phone (212) 492-3000
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

-$7.57M
Net Income

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 8, 2026 View on SEC
4 Insider stock transaction report April 7, 2026 View on SEC
4 Insider stock transaction report April 6, 2026 View on SEC
8-K Current report of material events March 25, 2026 View on SEC
10-K Annual financial report March 25, 2026 View on SEC
8-K Current report of material events March 20, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 18, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 11, 2026 View on SEC
8-K Current report of material events February 10, 2026 View on SEC
8-K Current report of material events February 3, 2026 View on SEC

Annual Reports

10-K March 25, 2026
  • DeepView® System offers 86% accuracy in burn assessment, significantly outperforming the 70% accuracy of experienced clinicians.
  • Secured a $150 million BARDA contract to fund critical clinical trials for FDA approval.
View Analysis

Material Events

8-K Leadership Change February 10, 2026
High Impact
  • New CEO Vincent Capone brings strong financial, legal, and operational expertise, ideal for commercialization phase.
  • DeepView® System, an AI-driven burn wound assessment device, is gearing up for its critical commercial launch.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.